Free Trial
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free JSPR Stock Alerts

Jasper Therapeutics (JSPR) Earnings Date, Estimates & Call Transcripts

Jasper Therapeutics logo
$0.91 +0.01 (+1.06%)
As of 04:00 PM Eastern
Compare

Jasper Therapeutics Earnings Summary

Jasper Therapeutics announced Q1 2026 earnings on May 14, 2026, reporting an EPS of -$0.38, which topped the consensus estimate of -$0.46 by $0.08. With a trailing EPS of -$3.23, Jasper Therapeutics' earnings are expected to grow next year, from ($1.81) to ($1.09) per share.

Upcoming Q2
Earnings Date
Aug. 12Before Market OpensEstimated
Consensus EPS
(May. 14)
-$0.46
Actual EPS
(May. 14)
-$0.38 Beat By $0.08

Q1 2026 Earnings Resources

JSPR Upcoming Earnings

Jasper Therapeutics' next earnings date is estimated for Wednesday, August 12, 2026, based on past reporting schedules.

Powered by Quartr
Get Jasper Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jasper Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

JSPR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Jasper Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.70-$0.37-$0.54
Q2 20262-$0.72-$0.37-$0.55
Q3 20262-$0.88-$0.47-$0.68
Q4 20262-$0.89-$0.71-$0.80

Jasper Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2026
(Estimated)		--------
5/14/2026Q1 2026-$0.46-$0.38+$0.08-$0.04--
3/30/2026Q4 2025-$0.79-$0.3250+$0.4650-$0.32--
11/10/2025Q3 2025-$1.01-$1.13 -$0.12-$1.13--
8/13/2025Q2 2025-$1.20-$1.74 -$0.54-$1.74--
5/12/2025Q1 2025-$1.17-$1.41 -$0.24-$1.41--
2/27/2025Q4 2024-$1.27-$1.62 -$0.35-$1.62--
11/7/2024--$1.09-$1.24 -$0.15-$1.24--
8/13/2024--$1.09-$0.97+$0.12-$0.97--

Data powered by Fiscal.ai.

Jasper Therapeutics Earnings - Frequently Asked Questions

Jasper Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 12th, 2026 based off last year's report dates. Learn more on JSPR's earnings history.

In the previous quarter, Jasper Therapeutics (NASDAQ:JSPR) reported ($0.38) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.46) by $0.08. Learn more on analysts' earnings estimate vs. JSPR's actual earnings.

Jasper Therapeutics (NASDAQ:JSPR) has a recorded net income of -$75.80 million. JSPR has generated -$3.23 earnings per share over the last four quarters.

Jasper Therapeutics' earnings are expected to grow from ($1.81) per share to ($1.09) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:JSPR) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...
Brownstone Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Elon Confirms SpaceX IPO For 6/12 [Act Now!]
Elon Musk has confirmed SpaceX will IPO on Friday, June 12, 2026, at a valuation of up to $2 trillion - potent...
Paradigm Press | Sponsoredtc pixel
I was right about SpaceX. Now here's the part that matters
Goldman Sachs and JP Morgan have already been tied to allocations surrounding the SpaceX deal. When the bigges...
The Oxford Club | Sponsoredtc pixel
June 4: The day smart money moves (not June 12)
Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...
Behind the Markets | Sponsoredtc pixel